Global Markets for Emerging Medical Device Technologies,

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 10, 2017 at 10:00 AM 77

Global Markets for Emerging Medical Device Technologies, 2021 with Profiles of Major Players in the Field

Dublin, April 10, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Markets for Emerging Medical Device Technologies" report to their offering. The Global Market for Emerging Medical Device Technologies Should Reach $90.8 billion by 2021 from $55.9 billion in 2016 at a CAGR of 10.2%

This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for emerging medical device technologies.

Traditional medical devices include devices (e.g., metallic stents, heart valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, needle based drug delivery, lab based diagnostics etc.) that have been in use over the last two to three decades for the treatment and management of various diseases.

Emerging medical device technologies include devices and technologies (e.g., bioresorbable implants, coated implants and balloons, transcatheter heart valves (TAVR, TMVR), electrophysiology, S-ICDs, cardioMEMS, wireless monitoring, wearable devices, needle-free drug delivery, capsule endoscopes, POC tests, companion diagnostics, etc.), which are relatively new (in practice over the last two to 10 years), advanced and have better outcomes in the treatment and management of world's deadly and chronic diseases.

This report provides: - An overview of the global markets for emerging medical device technologies. - Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021. - Evaluation of the market's dynamics, specifically growth drivers, inhibitors, and opportunities. - Analyses of segments within the overall market including: aesthetics/dermatology, cardiovascular, dental, diabetes care, gastroenterology, nephrology, urology, gynecology/women's health, medical imaging/visualization, in-vitro diagnostics, neurology, ophthalmology, orthopedic, drug delivery/pain management, surgical/wound care and patient management/monitoring. - An in depth look at growth driving factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years, technological advancements in medical devices, and the growing aging population - Product analysis detailing key marketed and pipeline devices - Profiles of major players in the field Key Topics Covered: 1: Introduction 2: Summary 3: Emerging Device Technologies In Cardiovascular Market - Cardiovascular Devices - Target Diseases And Economic Burden - Emerging Device Technologies For Heart Failure - Emerging Device Technologies For Electrophysiology (EP) - Emerging Device Technologies For Interventional Cardiology - Emerging Device Technologies For Endovascular Aneurysm/Aortic Repair (EVAR) - Emerging Device Technologies For Implantable Cardioverter Defibrillators (ICD) - Emerging Device Technologies For Peripheral Vascular Devices - Emerging Technologies For Transcatheter Heart Valve Technologies - Competitive Landscape In Emerging Cardiovascular Device Technologies Market - Other Cardiovascular Emerging Devices Technologies 4: Emerging Device Technologies In Orthopedic Market - Orthopedic Market - Target Diseases And Indications - Emerging Orthopedic Device Technologies - Emerging Device Technologies For Extremity Joint Reconstruction (Excluding Hip And Knee) - Emerging Device Technologies For Soft Tissue Fixation And Repair - Other Emerging Orthopedic Device Technologies - Competitive Landscape In Emerging Orthopedic Device Technologies Market 5: Emerging Device Technologies In Neurology Market - Neurovascular Devices - Emerging Neurovascular Device Technologies - Neuromodulation Devices - Emerging Neuromodulation Device Technologies - Other Emerging Neurology Device Technologies 6: Emerging Device Technologies In Diabetes Care Market - Diabetes Care Devices - Emerging Technologies In Diabetes Management - Epidemiology Of Diabetes - Competitive Landscape In The Cgm System And Insulin Pump Market 7: Emerging Diagnostic Technologies In In Vitro Diagnostics Market - Molecular Diagnostics - Emerging Cancer Molecular And Companion Diagnostics - Point-Of-Care (POC) Diagnostics 8: Needle-Free Drug Delivery Technologies - Needle-Free Drug Delivery Technologies - Marketed And R&D Pipeline Products 9: Emerging Device Technologies In Gi Endoscopy Market - Smart Pills And Technologies - Intragastric Balloon Systems 10: Other Emerging Medical Device Technologies - Iol And Cornea Implants - Advanced Wound Management - Implantable Drug Diffusion Pumps - Endoluminal Procedures - Multiparameter Vital Signs Monitors - Noninvasive Blood Pressure (Nibp) Monitors - Hemodialysis And Peritoneal Dialysis - Biochips Are Microchip-Based Sensors - Ear Implants - Mammography - Robotics And Computer-Assisted Surgery - Surgical Lasers - Positron Emission Tomography - Optical Imaging - Other FDA Approved And R&D Pipeline Device Technologies 11: Regulatory Structure - United States - European Union - Japan - Other Asia - Fda Technical Considerations - Fda Recalls And Safety Alerts 12: Pricing And Reimbursement 13: Conclusions: Outlook For Emerging Medical Device Technologies - Major Developments To Influence Market - Long-Term Outlook For Emerging Medical Device Technologies 14: Company Profiles - 3M - 480 Biomedical - Abbott Laboratories - Accumed Systems Inc. - AC-Gen Reading Life - Actuated Medical - Adient Medical - Advanced Research Technologies Inc. - Aegeria Soft Tissue - Aethlon Medical Inc. - Afreeze - Alere Inc. - Allergan Plc - Allurion Technologies - Amaranth Medical - A.M.I. (Agency For Medical Innovations) - Angiodynamics - Apama Medical - Applied Medical - Apollo Endosurgery - Apocell - Aspire Bariatrics - Atricure - Audax Medical - Bard - Baronova - Barosense (Subsidiary Of Boston Scientific) - Baxter International Inc. - Bellerophon Therapeutics - Beta-Stim Ltd. - BFKW - Biocept - Biomerieux - Bioness - Bio-Scaffold International - Biosense Webster Inc. (Subsidiary Of Johnson & Johnson) - Biosurface Engineering Technologies - Biotheranostics - Biotronik - Boston Scientific Corp. - Bracco - Callisyn Biomedical Inc. - Cardiosolutions Inc. - Cardiovascular Systems Inc. - Carmell Therapeutics Corp. - Cervel Neurotech - Colibri Heart Valve - Cook Group Inc. - Consort Medical - Coramaze Technologies Gmbh - Coras Medical - Crospon - CVTEC Cerebrovascular Technologies - Edwards Lifesciences - Electrical Geodesics Inc. - Elixir Medical - Endobetix - Endogastric Solutions - Endologix - Endoretics Inc. - Endosphere - Endospan - Enteromedics Inc. - Gaudi Vascular - Gelesis - Gentis - Getinge Ab - GI Dynamics - GI Windows Inc. - Greatbatch - Guided Delivery Systems - Hansen Medical Inc. - Harpoon Medical - Heartware - Helioscopie - Hologic - Icellate - Illumina - Implants Intl. - Inivata Ltd. - Inspiremd - Integra Lifesciences - Interface Biologics - Intrapace Inc. - Invivo Therapeutics Corp. - Jenavalve Technology - Keystone Heart - Lifetech Scientific - Livanova - Lombard Medical Technologies - Lonestar Heart Inc. - Lucigen - Mainstay Medical - Medtronic - Metacure - Metamark Genetics - Micardia Corp. - Microport Scientific - Microtransponder - Mindray Medical International Ltd. - Miraca Holdings - Mitrassist - MSDX Inc. - Myriad Genetics Inc. - Nanonerve Inc. - Neovasc - Nesher Technologies Inc. - Neurometrix - Neurorecovery Technologies - Novartis - Obalon Therapeutics - OHMX - Onciomed Inc. - Oncogenesis - Opto Circuits (India) Ltd. - Orasure Technologies - Orpyx Medical Technologies Inc. - Orthofix Intl. - Osteotec Ltd. - Palmaz Scientific Inc. - Penumbra - Plensat Inc. - Quanterix Corp. - Renishaw - Reshape Medical - REVA Medical Inc. - Rijuven - Sarl Cousin Biotech - Satiety Inc. - Scientific Intake - Sensate - Setpoint Medical - Shape Memory Medical Inc. - Sklar Corp. - Slimedics Ltd. - Smith & Nephew - Soft Tissue Regeneration Inc. - Soterix Medical Inc. - Spatz Fgia - Spectranetics - St. Jude Medical - Stryker - Symetis - Sysmex Corp. - TAL Medical - Terumo Corp. - Tissue Regeneration Systems - Tissue Regenix Group Plc - Tomowave Laboratories - Tornier Inc. - Transcatheter Technologies - Transenterix - Trivitron Healthcare - Ttk Healthcare - Tulip Medical Ltd. - USGI Medical - Valeant Pharmaceuticals Intl. - Valentx - Vigilant Biosciences - W. L. Gore And Associates - Wright Medical Technology Inc. - Xeltis - Ypsomed Holding Ag - Zimmer Biomet 15: Appendix A Industry And Professional Organizations - American Association For Cancer Research (Aacr) - American Society For Reproductive Medicine (Asrm) - American Society Of Clinical Oncology (Asco) - Center For Devices And Radiological Health - Centers For Medicare & Medicaid Services - Eudamed - Food And Drug Administration (Fda) - Global Cancer Foundation - Hormone Foundation - International Agency For Research On Cancer - International Federation Of Pharmaceutical Manufacturers & Associations (Ifpma) - International Osteoporosis Foundation (Iof) - International Diabetes Federation (Idf) - National Center For Biotechnology Information (Ncbi) - National Institute Of Aging (Nia) - PMDA - World Cancer Research Fund International For more information about this report visit http://www.researchandmarkets.com/research/xp...al_markets

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Medical Devices

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Luvme Hair Offers Wig Variety for Winter Fashion

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...